MidhatFarooqiMD
Pathology • Kansas City, MOMolecular Genetics, Clinical Pathology
Director of Molecular Oncology, Children's Mercy Kansas City
Dr. Farooqi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2401 Gillham Road
Kansas City, MO 64108
Summary
- Dr. Midhat Farooqi is a Pathologist based in Kansas City, MO, specializing in molecular genetics and clinical pathology. He completed his residency in anatomic and clinical pathology at the University of Pennsylvania Health System and University of Texas Southwestern Medical Center. Dr. Farooqi holds an MD and PhD from the University of Texas Southwestern Medical School. His recent publications include studies on epigenetic priming in acute lymphoblastic leukemia, methods for detecting gene fusions in pediatric cancer samples, and tools for discovering somatic variants in tumor genomes, which appear in journals such as Nature Biotechnology, Haematologica, and Cancers.
Education & Training
University of Texas Southwestern Medical CenterResidency, Pathology-Anatomic and Clinical, 2013 - 2015
University of Pennsylvania Health SystemResidency, Pathology-Anatomic and Clinical, 2012 - 2013
University of Texas Southwestern Medical SchoolClass of 2012, MD, PhD
Certifications & Licensure
MO State Medical License 2016 - 2026
KS State Medical License 2016 - 2025
PA State Medical License 2012 - 2016
American Board of Pathology Pathology - Clinical- American Board of Pathology Molecular Genetic Pathology
- American Board of Pathology Pathology - Molecular Genetic
Publications & Presentations
PubMed
- 1 citationsAzacitidine as epigenetic priming for chemotherapy is safe and well-tolerated in infants with newly diagnosed-rearranged acute lymphoblastic leukemia: Children's Oncol...Erin M Guest, John A Kairalla, Meenakshi Devidas, Emily Hibbitts, Andrew J Carroll
Haematologica. 2024-12-01 - Evaluation of Hi-C Sequencing for Detection of Gene Fusions in Hematologic and Solid Tumor Pediatric Cancer Samples.Anthony D Schmitt, Kristin Sikkink, Atif A Ahmed, Shadi Melnyk, Derek Reid
Cancers. 2024-08-23 - 1 citationsDeepSomatic: Accurate somatic small variant discovery for multiple sequencing technologies.Jimin Park, Daniel E Cook, Pi-Chuan Chang, Alexey Kolesnikov, Lucas Brambrink
Biorxiv. 2024-08-19
Press Mentions
Children’s Mercy Kansas City Tackles the Unique Complexity of Pediatric CancerMarch 10th, 2023
Braden`S Hope for Childhood Cancer Gifts Children’s Mercy Doctor $1 Million Grant to Further ResearchOctober 1st, 2019
Scientists Finish the Human Genome at LastNovember 16th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
